Yizong Tongluo formula attenuates idiopathic pulmonary fibrosis and inflammatory injury by inhibiting HIF-1α/LSH/SCD1-mediated ferroptosis. This evidence concerns the gene HIF1A and idiopathic pulmonary fibrosis.